Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes

The Drug Delivery Systems (DDS) industry has gone through extensive changes in the last few decades due to its increasing role in driving patient care and outcomes. It has pushed players to develop new strategies that cover the dynamic needs of their biopharmaceutical customers.

Join our guest Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma, Aude Ouensanga, Partner at Alira Health, and our host Kenny Carberry, Associate Director of Clinical Development, Alira Health as they discuss the impact of COVID-19, the evolution of the industry and its future, and the relationship between DDS organizations and the pharma industry by sharing insights and experiences from the perspective of a multinational healthcare consulting firm, and a global manufacturer and supplier of consumer dispensing packaging and drug delivery services.

For recent insights on the Drug Delivery Devices industry, download our latest report here.

LISTEN TO THE EPISODE BELOW

Related news

M&A MedTech Pharma
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
Pharma
Events December 23, 2021
Event: Presentation of the 2021 BioRegion Report
We are thrilled to announce that Alira Health has contributed to the BioRegion Report 2021,
Clinical Pharma
Publications December 21, 2021
An Insider Look at Vaccines: Yesterday, Today, Tomorrow
The COVID-19 pandemic has put vaccines in the spotlight. The pandemic has given the industry a considerable boost, and with lessons learned during the development and roll-out(...)
Advanced Analytics Digital Health Pharma Research & Development
Publications December 10, 2021
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Patient Engagement
Publications December 7, 2021
Patient Involvement in Health Technology Assessment Agencies
Learn more about the level of current patient involvement in health technology assessment (HTA) in the European, US, and Canadian HTA agencies with our systematic literature review(...)
Pharma
Events November 21, 2021
Webinar: RWE in Pharma: An Expert Panel Discussion
Join Catia Proenca, PhD, for a webinar on RWE in Pharma.
Patient Engagement
Publications November 18, 2021
Creating a Lifecycle of Patient Engagement
Discover how you can create a lifecycle of patient engagement to benefit patients and provide you with impactful insights and measurable results to your business.
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.